SANDOSTATIN LAR

Serial Number 74478541
Registration 1904047
800

Registration Progress

Application Filed
Jan 11, 1994
Under Examination
Approved for Publication
Mar 17, 1995
Published for Opposition
Apr 18, 1995
Registered
Jul 11, 1995

Trademark Image

SANDOSTATIN LAR

Basic Information

Serial Number
74478541
Registration Number
1904047
Filing Date
January 11, 1994
Registration Date
July 11, 1995
Published for Opposition
April 18, 1995
Renewal Date
July 11, 2025
Drawing Code
1

Status Summary

Current Status
Active
Status Code
800
Status Date
Jun 16, 2025
Registration
Registered
Classes
005

Rights Holder

NOVARTIS AG

03
Address
CH-4002
BASEL 4002
CH

Ownership History

SANDOZ PHARMACEUTICALS CORPORATION

Original Applicant
03
E. Hanover, NJ

SANDOZ PHARMACEUTICALS CORPORATION

Owner at Publication
03
E. Hanover, NJ

SANDOZ PHARMACEUTICALS CORPORATION

Original Registrant
03
E. Hanover, NJ

NOVARTIS AG

New Owner After Registration #11
03
BASEL CH

Legal Representation

Attorney
MAURY M. TEPPER, III

USPTO Deadlines

Next Deadline
3488 days remaining
Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 19950711)
Due Date
July 11, 2035
Grace Period Ends
January 11, 2036

Application History

28 events
Date Code Type Description Documents
Jun 16, 2025 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED Loading...
Jun 16, 2025 RNL3 Q REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS) Loading...
Jun 16, 2025 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Loading...
Jun 16, 2025 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Jan 9, 2025 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
Jul 11, 2024 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Loading...
Jun 9, 2015 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED Loading...
Jun 9, 2015 RNL2 Q REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS) Loading...
Jun 9, 2015 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Loading...
Jun 9, 2015 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
May 19, 2015 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
Jun 19, 2009 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Sep 2, 2005 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) Loading...
Sep 2, 2005 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Loading...
Aug 17, 2005 PLGL A ASSIGNED TO PARALEGAL Loading...
May 27, 2005 89AF I REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED Loading...
May 27, 2005 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
Dec 19, 2004 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Dec 6, 2004 MAIL I PAPER RECEIVED Loading...
Aug 14, 2001 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Jul 9, 2001 815F I REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED Loading...
Jul 11, 1995 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Apr 18, 1995 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 17, 1995 NPUB O NOTICE OF PUBLICATION Loading...
Oct 17, 1994 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 19, 1994 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 27, 1994 CNRT F NON-FINAL ACTION MAILED Loading...
May 26, 1994 DOCK D ASSIGNED TO EXAMINER Loading...

Detailed Classifications

Class 005
medicinal preparation useful in the management of gastrointestinal endocrine tumors
First Use Anywhere: Feb 10, 1992
First Use in Commerce: Feb 10, 1992

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"LAR"